257 related articles for article (PubMed ID: 31783774)
1. Sodium valproate induced acute pancreatitis in a bipolar disorder patient: a case report.
Huang W; Ren X; Shen F; Xing B
BMC Pharmacol Toxicol; 2019 Nov; 20(1):71. PubMed ID: 31783774
[TBL] [Abstract][Full Text] [Related]
2. Development of acute pancreatitis caused by sodium valproate in a patient with bipolar disorder on hemodialysis for chronic renal failure: a case report.
Okayasu H; Shinozaki T; Osone A; Ozeki Y; Shimoda K
BMC Psychiatry; 2014 Mar; 14():93. PubMed ID: 24679075
[TBL] [Abstract][Full Text] [Related]
3. Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol.
Laghate VD; Gupta SB
J Assoc Physicians India; 2004 Mar; 52():257-8. PubMed ID: 15636323
[TBL] [Abstract][Full Text] [Related]
4. [A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder].
Ricard C; Martin K; Tournier M; Bégaud B; Verdoux H
Encephale; 2005; 31(1 Pt 1):98-101. PubMed ID: 15971646
[TBL] [Abstract][Full Text] [Related]
5. [Inappropriate antidiuretic hormone secretion induced by sodium valproate].
Bève E; Beck E; Pinto E; Ansseau M
Rev Med Liege; 2010 Jan; 65(1):6-9. PubMed ID: 20222501
[TBL] [Abstract][Full Text] [Related]
6. Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report.
Alvarez P; Papaseit E; Pérez V; Bulbena A; Farré M
Actas Esp Psiquiatr; 2019 Jan; 47(1):33-6. PubMed ID: 30724329
[No Abstract] [Full Text] [Related]
7. Valproate in acute mania: is our practice evidence based?
Vasudev K; Mead A; Macritchie K; Young AH
Int J Health Care Qual Assur; 2012; 25(1):41-52. PubMed ID: 22455007
[TBL] [Abstract][Full Text] [Related]
8. Disodium valproate: new preparation. An alternative for acute mania after lithium failure or intolerance.
Prescrire Int; 2001 Aug; 10(54):113-5. PubMed ID: 11718180
[TBL] [Abstract][Full Text] [Related]
9. [Clinical standing of valproate treatment of bipolar disorders].
Grunze H; Adli M; Bauer M; Berger M; Bergmann A; Bräunig P; Bschor T; Falkai P; Gastpar M; Greil W; Kasper S; Krüger S; Laux G; Müller WE; Naber D; Walden J
Fortschr Neurol Psychiatr; 2007 Apr; 75(4):220-35. PubMed ID: 17427043
[TBL] [Abstract][Full Text] [Related]
10. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
[TBL] [Abstract][Full Text] [Related]
12. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
Sekhar S; Kalra B; Mendhekar DN; Tekur U
J Clin Pharmacol; 2010 Jun; 50(6):688-92. PubMed ID: 20075184
[TBL] [Abstract][Full Text] [Related]
14. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
15. [Valproate induced hypoactive delirium in a bipolar disorder patient with psychotic features].
Ozen S; Bülbül I; Soyuçok E
Turk Psikiyatri Derg; 2010; 21(1):79-84. PubMed ID: 20204907
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.
Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
Int Clin Psychopharmacol; 2003 Mar; 18(2):73-9. PubMed ID: 12598817
[TBL] [Abstract][Full Text] [Related]
17. Algorithms for the pharmacotherapy of bipolar disorder.
Motohashi N
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
[TBL] [Abstract][Full Text] [Related]
18. Magnesium valproate-induced pedal edema on chronic therapy: A rare adverse drug reaction.
Prajapati H; Kansal D; Negi R
Indian J Pharmacol; 2017; 49(5):399-400. PubMed ID: 29515282
[TBL] [Abstract][Full Text] [Related]
19. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
[TBL] [Abstract][Full Text] [Related]
20. Rapid reversal of corticosteroid-induced mania with sodium valproate: a case series of 20 patients.
Roxanas MG; Hunt GE
Psychosomatics; 2012; 53(6):575-81. PubMed ID: 23157995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
